Jin Woo Song

Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome

Jin Woo Song, Sang‐Bum Hong, Cheong-Su Lim et al. · European Respiratory Journal · 2010 · 772 citations · Full text

Acute Lung Injury, Asthma, Antifibrotic Therapy +17

Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

Athol U. Wells, Kevin R. Flaherty, Kevin K. Brown et al. · The Lancet Respiratory Medicine · 2020 · 522 citations · Full text

Inbuild Trial, Parallel-group Trial, Advanced Lung Disease +5

Gene Expression Profiles of Acute Exacerbations of Idiopathic Pulmonary Fibrosis

Kazuhisa Konishi, Kevin F. Gibson, Kathleen O. Lindell et al. · American Journal of Respiratory and Critical Care Medicine · 2009 · 329 citations

Viral Infection in Acute Exacerbation of Idiopathic Pulmonary Fibrosis

Sharon Chao Wootton, Dong Soon Kim, Yasuhiro Kondoh et al. · American Journal of Respiratory and Critical Care Medicine · 2011 · 278 citations · Full text

Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trial

Ganesh Raghu, Kevin M. Brown, Harold R. Collard et al. · The Lancet Respiratory Medicine · 2016 · 271 citations

Simtuzumab Versus Placebo, Idiopathic Pulmonary Fibrosis, Pulmonary Pharmacology +5